Canlyniadau Chwilio - Barry Antonacci
- Dangos 1 - 2 canlyniadau o 2
-
1
In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i> gan Anthony Cacciapuoti, David Loebenberg, Erik Corcoran, Fred Menzel, E. L. Moss, Christine Norris, Monika Michalski, Kimberly Raynor, Judith Halpern, Cara Mendrick, Brian M. Arnold, Barry Antonacci, Raulo Parmegiani, T. Yarosh-Tomaine, George H. Miller, R S Hare
Cyhoeddwyd 2000Artigo -
2
Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors gan Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Michelle F. Waldman, Cara Mendrick, Nathaniel H. Brown, Paul A. Mann, Andrew S. Chau, Reena Patel, Nicholas P. Bauman, Christine Norris, Barry Antonacci, Maya Gurnani, Anthony Cacciapuoti, Paul M. McNicholas, Samuel B. Wainhaus, R. Jason Herr, Rongze Kuang, Robert Aslanian, Pauline C. Ting, Todd A. Black
Cyhoeddwyd 2011Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Antifungal
Biology
Candida albicans
Fluconazole
Microbiology
Pharmacology
Amphotericin B
Aspergillus
Aspergillus flavus
Aspergillus fumigatus
Biochemistry
Biotechnology
Candida glabrata
Caspofungin
Chemistry
Cryptococcosis
Cryptococcus
Cryptococcus neoformans
Echinocandin
Echinocandins
In vitro
In vivo
Itraconazole
Organic chemistry
Posaconazole
Triazole